Indorama Ventures Public Company Limited Overview
| Attribute | Detail | Source / Note |
|---|---|---|
| Legal name | Indorama Ventures Public Company Limited | SET listing |
| Former names | Operating predecessor: Indorama Polymers Public Company Limited (PET resin business). IVL became the listed holding vehicle in 2010. | (prior disclosure, not re-verified) |
| Founding year | 1994 (group's Thai PET operations) | Company profile data (roic.ai); IVL marked its "35th anniversary" in the 2025 One Report, which dates group origins to about 1990 under a broader definition |
| Incorporation jurisdiction | Kingdom of Thailand (public limited company); incorporated 2003 | (prior disclosure, not re-verified) |
| Headquarters | 75/102 Ocean Tower 2, 37th Floor, Soi Sukhumvit 19, Bangkok 10110, Thailand | (prior disclosure, not re-verified) |
| Primary listing | Stock Exchange of Thailand (SET), ticker IVL; NVDR line IVL-R | SET |
| Other trading lines | OTC (US) INDO.Y; Frankfurt/Stuttgart NVDR line (I93 / A1CXKA) | Simply Wall St; Börse Stuttgart |
| ISIN | TH1027010012 (ordinary shares) | Parqet |
| CUSIP | Not applicable / n/v | No US primary listing |
| Fiscal year end | 31 December | S&P / SET |
| Shares outstanding | About 5,614.6 million ordinary shares (unchanged FY2021 to 2026) | S&P standardized balance sheet |
| Employees (latest) | About 26,000 worldwide (company figure cited in Eurofound factsheet, March 2026); "more than 25,000" (Eurofound, May 2026) | Eurofound ERM 204357 / 300431 |
| Employees (3-year trend) | "Over 26,000" (2022, D&B profile) → about 26,000 (2026). Year-by-year audited headcount n/v; IVL 2.0 included headcount reductions in 2025 per Q2 2025 commentary | D&B; Parqet / investing.com summary |
| Auditor | KPMG Phoomchai Audit Ltd. | (prior disclosure, not re-verified for FY2025) |
| Share price | THB 27.75 (close, 6 October 2026) | SET quote page |
| Market capitalisation | About THB 155.8 billion (5,614.6m shares × THB 27.75), about USD 4.7 billion at about THB 33/USD | Calculated |
| Website | www.indoramaventures.com (beta.indoramaventures.com hosts newer releases) | Company |
| Controlling shareholder | Indorama Resources Ltd. (Lohia family vehicle), majority holder | DAOL Securities shareholder table; exact 2026 % n/v |
| Group CEO | Aloke Lohia (Vice Chairman and Group CEO) | IVL releases |
| Chairman | Sri Prakash Lohia (Non-Executive) | IVL board disclosure |
| Credit rating (domestic) | TRIS Rating: company rating AA-; outlook revised to Negative (2024). 2025 to 2026 rating actions n/v | TRIS Rating |
| Manufacturing footprint | 117 manufacturing locations in 31 countries (pre-2025 baseline, before ongoing closures and divestments) | World Economic Forum organisation profile |
Indorama Ventures is the world's largest integrated producer in the polyester and PET value chain and a leading global maker of surfactants and technical fibres. Its operations span Asia-Pacific, the Americas, Europe and Africa. The group converts US shale-advantaged ethane and global aromatics into intermediates (PTA, MEG, EO), PET resin and recycled PET. It then extends downstream into rigid packaging (Indovida), specialty surfactants (Indovinya) and fibres for hygiene, mobility and lifestyle markets. Its core proposition is "local-for-local" supply to global consumer brands, backed by scale, integration and a large recycling platform that has processed more than 166 billion PET bottles. After a three-year cyclical trough (2023 to 2025) marked by Chinese overcapacity, cumulative net losses and leverage above 9x net debt to EBITDA, IVL has spent the IVL 2.0 programme closing Western assets and cutting fixed costs. It now targets a doubling of EBITDA by 2028. A sharp 2Q26 spread recovery returned the group to profit.
What the Company Does
IVL is a vertically integrated petrochemical and materials company. Under its current four-segment structure (in place since 1Q25, when Indovida was carved out of Combined PET), it operates as follows.
-
Combined PET (CPET) is the core engine. It produces PET resin (commodity and specialty high-value-added grades), recycled PET (rPET), and the upstream intermediates PTA, PIA, MEG and EO. Through its US Gulf Coast assets it also produces ethylene and MTBE. CPET earns a "spread" between feedstock (paraxylene, ethane/ethylene) and PET/intermediate selling prices. In 1H26 it generated roughly two-thirds or more of group EBITDA.
-
Indovida (Packaging) converts PET resin into preforms, closures and bottles for beverage and FMCG brand owners, mainly in emerging markets. It is in the process of merging into EPL Limited (India), which would make IVL the 51.8% promoter of a listed, multi-format packaging company.
-
Indovinya (Surfactants / specialty chemicals) was formed from the Huntsman chemical intermediates and surfactants acquisition (2020) and the Oxiteno acquisition in Brazil (April 2022). It sells ethoxylates, amines, glycol ethers and specialty surfactants into home and personal care, crop protection, coatings, and energy and resources. Its business is split into High Value Applications (HVA) and Essentials. HVA contributed about 80% of Indovinya EBITDA in 2Q26.
-
Fibers produces polyester, polyolefin and nylon fibres and yarns across three verticals: Hygiene (nonwovens inputs), Mobility (tyre cord, airbag and safety yarns) and Lifestyle (apparel and home textiles, including Trevira flame-retardant fibres).
Business and Revenue Model
| Revenue model element | Characterisation |
|---|---|
| Product vs. service | Almost entirely product sales (physical chemicals, resins, fibres, packaging). Service, subscription and licensing revenue is negligible or not separately disclosed. |
| Pricing mechanism | Largely cost-plus and spread-based. Many PET and intermediate contracts pass through raw-material costs (paraxylene, MEG, ethylene) with a conversion margin, so reported revenue swings with oil and feedstock prices even when margins are stable. |
| Margin driver | Industry spreads (for example, the China integrated PET spread rose to USD 279/t in 2Q26 from USD 176/t in 1Q26 per CLSA), import parity in Western markets (ocean freight, tariffs), operating rates, and mix of High Value Added (HVA) products. |
| Inventory effect | IVL reports "Adjusted" or "Core" EBITDA before inventory gains and losses because rising or falling feedstock prices create sizeable stock gains or losses (for example, a THB 779 million inventory loss in 2Q25 per DAOL). |
| Volume | Group sales volume was about 3.1 to 3.6 million tonnes per quarter in 2024 to 2025 (3.64 MMT in 2Q24; 3.3 MMT in 2Q25; 3.1 MMT in 4Q25). |
Value-Chain Position
| Stage | IVL assets / products |
|---|---|
| Feedstock / olefins | US ethane cracker at Lake Charles, Louisiana (ethylene), which gives a shale-gas cost advantage |
| Intermediates | PTA, PIA, MEG, EO, MTBE |
| Polymers | PET resin (virgin and recycled), specialty PET |
| Downstream conversion | Preforms, closures and bottles (Indovida); fibres and yarns (Fibers); surfactant formulations (Indovinya) |
| End-of-life | PET bottle recycling (rPET) and textile-to-textile recycling (Jiaren JV) |
IVL is positioned across upstream intermediates → midstream polymers → downstream converted products:
Customers and End-Markets
| End-market | Segment exposure | Customer type |
|---|---|---|
| Beverages and food packaging | CPET, Indovida | Global soft-drink, water and food brand owners and converters |
| Home and personal care | Indovinya, Fibers (Hygiene) | FMCG majors and formulators |
| Hygiene (diapers, wipes, feminine care) | Fibers (Hygiene) | Nonwovens producers |
| Automotive and mobility | Fibers (Mobility), Indovinya | Tyre makers, airbag and seatbelt manufacturers |
| Agrochemicals | Indovinya (crop solutions) | Crop protection formulators |
| Coatings and industrial | Indovinya | Paint and coatings producers |
| Energy and resources | Indovinya | Oilfield and mining chemicals customers |
| Apparel, home and contract textiles | Fibers (Lifestyle) | Textile mills and brands |
| Fuel additives | CPET intermediates (MTBE) | Refiners and blenders |
Company Self-Description vs. Independent Characterisation
Company self-description (paraphrased from releases): IVL describes itself as a global sustainable chemical producer with diversified international businesses integrated across the petrochemical value chain. It says its products serve daily necessities and that its local-for-local model gives resilience through the cycle. In the 1H26 release, management framed the key test as converting its platform advantages (scale, integration, global footprint, customer positions) into more consistent earnings, cash generation and returns through the cycle.
Independent characterisation: In economic terms IVL is a cyclical, spread-driven commodity chemical company with a growing but still minority layer of specialty exposure (Indovinya HVA, specialty PET, technical fibres, packaging). Several features define its risk profile:
-
Exposure to Chinese PTA/PET overcapacity, which compressed benchmark spreads from 2023 to 2025.
-
A Western-heavy asset base. Management said in 2022 that about two-thirds of the portfolio sat in Western markets. This base benefits from import parity and tariffs but suffers from high European energy costs.
-
A balance sheet built during an acquisition-led era (2010 to 2022) that became over-levered when the cycle turned.
The IVL 2.0 pivot is explicitly a shift from acquisition-led growth to cash-flow discipline.
Strategy
Strategic Themes from Recent Disclosures
IVL 2.0 (2024 to 2026). Announced in March 2024, this three-year programme focuses on four themes, summarised from the FY24 and 1H25 releases:
Footprint and asset optimisation: closing or divesting uncompetitive Western assets.
Operational excellence and cost: structural fixed-cost reduction of THB 8.2bn since 2023 (2025 One Report summary). This included a USD 48m additional fixed-cost reduction by end-2024 and USD 51m net of inflation in 1H25.
Deleveraging and cash flow: a shift from an acquisition-led model to a disciplined, cash-flow-driven one; finance-policy review to reduce FX impacts.
Digital and leadership: next-generation digital tools and leadership programmes.
Management frames IVL 2.0 through a "VUCA" lens (Vision, Understanding, Clarity, Agility).
2026 to 2028 plan (Capital Markets Day, 4 March 2026):
-
Adds a "SOAR" mindset (Strengths, Opportunities, Aspirations, Results) on top of VUCA.
-
Targets a doubling of EBITDA by 2028, driven mainly by self-help (cost optimisation, inventory discipline, portfolio sharpening).
-
About 95% of EBITDA to come from "advantaged, scalable platforms": Integrated PET, surfactants, technical textiles and packaging.
Deleveraging target: net debt to equity of about 1.1x and net debt to EBITDA below 3.0x (by 2028).
Growth focus: Indovinya, Indovida and the "shale-to-PET" platform.
Enablers: Global Capability Centre scaling, Sales and Operations Execution (S&OE) discipline, and digital integration.
1H26 priorities:
-
Deliver sustainable earnings under normalised spreads.
-
Convert earnings into free cash flow.
-
Reduce absolute net debt.
-
Improve returns on capital.
Strategic Initiatives Register (last 24 months)
| Initiative | Date | Type | Targets / status |
|---|---|---|---|
| IVL 2.0 asset optimisation (closures of Rotterdam and Montréal; Sines divestment) | 2024 to 2025 | Footprint | Completed; operating rates up 8% in 2024 |
| Fixed-cost reduction programme | 2023 to 2025 | Cost | THB 8.2bn structural reductions achieved since 2023 |
| Indovida carve-out as fourth segment | 1Q25 | Portfolio | Completed; earlier plans for Indovinya and Indovida IPOs (FY24 release) evolved into the EPL merger |
| EPL 24.9% investment | May 2025 | Partnership / M&A | Completed (about INR 1,900 crore) |
| "NorthStar" programme (further cost cuts, site optimisation, property sales) | Nov 2025 (3Q25) | Cost / asset monetisation | Ongoing (Investing.com via Parqet) |
| Jiaren textile-to-textile JV | Nov 2025 | Circularity / partnership | Up to 100 kt/yr textile-recycled PET; "double-digit million-dollar" equity injection |
| CMD 2026 to 2028 plan | Mar 2026 | Strategy | EBITDA x2 by 2028; ND/E about 1.1x; ND/EBITDA below 3x |
| EPL–Indovida merger | Mar 2026 | M&A | IVL 51.8%; completion expected within about 12 months |
| European Mobility exits (Longlaville, Steinfort) | 2026 to 2027 | Footprint | In progress |
| Inventory and working-capital discipline (S&OE) | 2025 to 2026 | Operations | Inventory turnover 5.0x in 2Q26 vs. 4.7x at end-2025 |
| rPET scale-up: 50 billion bottles per year ambition | Ongoing | Sustainability | Last 50bn bottles recycled in 2.5 years; more than 166bn cumulative |
| Vision 2030 sustainability goals | Since 2021 | ESG | See Section 20 |
Medium-Term Financial Targets and Guidance
| Target | Horizon | Status (latest) |
|---|---|---|
| Double EBITDA (vs. 2025 base, implied) | 2,028 | FY2025 EBITDA THB 31 to 32bn (company basis). 1H26 already THB 29.7bn. Management "confident" in 2026 expectations and 2028 ambitions (Aug 2026) |
| Net debt to equity of about 1.1x | 2,028 | 1.56x at 2Q26. The 2026 CMD interim target was reached early |
| Net debt to EBITDA below 3.0x | 2,028 | 5.4x at 2Q26 (CLSA) |
| 95% of EBITDA from advantaged platforms | 2026 to 2028 | Stated as achieved / ongoing |
| Capex | 2024 to 2026 | THB 16 to 20bn per year (TRIS assumption); actual THB 16.0bn (FY2024) and 17.9bn (FY2025) |
Products & Services
Note: IVL does not publish list prices. Pricing is contract- or spread-based throughout. Launch years are given where disclosed; otherwise n/v.
Combined PET (CPET)
| Product line | Description and specifications | Target customer | Launch / status | Pricing model |
|---|---|---|---|---|
| Bottle-grade PET resin | Polyethylene terephthalate resin for CSD, water, edible oil and food containers. IVL is the world's largest PET producer (TRIS Rating) | Converters and brand owners | Core since 1990s | Feedstock pass-through plus conversion margin |
| Specialty PET (HVA) | Barrier, hot-fill, high-IV, heat-resistant and modified PET grades. Outperformed in FY2024 and offset commodity PET margins (FY24 release) | Specialty packaging and technical applications | Ongoing | Premium over commodity spread |
| Recycled PET (rPET), "Deja" sustainability brand | Mechanically recycled bottle-to-bottle PET flake and resin. More than 166 billion bottles recycled cumulatively (2025 One Report summary); ambition to recycle 50 billion bottles per year, with the last 50 billion recycled in 2.5 years (1H25 release) | Beverage brand owners with recycled-content targets | Deja brand (prior disclosure); capacity expansion ongoing | Premium linked to bale cost and regulation |
| PTA (purified terephthalic acid) | Key PET and polyester feedstock. Footprint reduced after Rotterdam and Montréal closures and the Sines divestment | Internal consumption and merchant sales | Rationalised 2024 to 2025 | Paraxylene-linked |
| PIA (purified isophthalic acid) | Co-monomer for PET and resins | PET and resin producers | (prior disclosure) | Contract |
| MEG / EO | Monoethylene glycol and ethylene oxide from US Gulf Coast integrated assets. Integrated MEG margins improved in FY2024 | Internal (PET, Indovinya) and merchant | Since Huntsman acquisition (2020) | Ethylene/ethane-linked |
| Ethylene | From Lake Charles, Louisiana cracker (ethane feed) | Internal feed for EO/MEG | Planned turnarounds in 1Q25 | Internal transfer |
| MTBE | Fuel oxygenate. Margins pressured by new third-party US capacity in FY2024 | Refiners and blenders | Intermediate Chemicals | Gasoline-octane-linked |
Indovida (Packaging)
| Product line | Description | Target customer | Notes |
|---|---|---|---|
| PET preforms | Injection-moulded preforms for blow-moulding into bottles | Beverage bottlers, FMCG | Emerging-markets footprint including India and Vietnam (Vietnamese packaging acquisition, 2022) |
| Closures | Caps and closures for beverage and FMCG | Bottlers | n/v detail |
| Bottles / rigid packaging | Finished rigid PET containers | FMCG, beverages | 2Q26 volume 0.09 mt (+11% YoY) |
| Combined EPL + Indovida offer (pending) | Flexible laminated tubes (EPL) plus rigid PET (Indovida). Merged entity valued at about USD 2bn with about USD 1bn of revenue | Oral care, beauty, pharma, food, beverage | Completion expected within 12 months of March 2026 |
Indovinya (Surfactants and Specialty Chemicals)
| Product family / market | Description | Target customer | Notes |
|---|---|---|---|
| Home and personal care surfactants | Ethoxylates, alkoxylates, amphoteric and specialty surfactants | Detergent and cosmetics formulators | HVA vertical; North America recovery in 2024 |
| Crop solutions | Adjuvants, emulsifiers and dispersants for agrochemical formulations | Crop protection companies | HVA; strong South American exposure (ex-Oxiteno) |
| Coatings | Surfactants and solvents for paints and coatings | Coatings producers | HVA / Essentials |
| Energy and resources | Oilfield, mining and fuel-additive chemicals | Oil and gas, mining | (ex-Huntsman) |
| Amines and ethanolamines; glycol ethers | Intermediates and performance chemicals | Industrial users | Essentials-type |
| Essentials (palm/oleo-based) | Commodity-type surfactant feedstocks. Hit by higher palm input costs in 1H25 | Broad industrial | Essentials vertical |
HVA share: About 80% of Indovinya EBITDA in 2Q26 (Kaohoon). Flagship: commercial-excellence-driven HVA portfolio (company release).
Fibers
| Vertical / product | Description | Target customer | Notes |
|---|---|---|---|
| Hygiene: polyolefin and bicomponent staple fibres | Fibres for nonwoven diapers, wipes and feminine care | Nonwovens roll-goods producers | Stable demand in 2Q26; hygiene volumes up in 2024 |
| Mobility: polyester and nylon tyre cord, industrial yarns | High-tenacity yarns and cord fabrics for tyres | Tyre makers | European sites Longlaville (closed June 2026) and Steinfort (closure announced) |
| Mobility: airbag and safety yarns | Nylon/polyester yarns for airbags and seatbelts | Automotive safety tier-1s | Asian competition cited for Steinfort closure |
| Lifestyle: polyester staple fibre and filament | Apparel, home textiles | Textile mills and brands | Weak 2025 to 2026 demand; Brazil fibre unit sold April 2026 |
| Trevira CS / Trevira CS Eco | Inherently flame-retardant polyester fibres and yarns for contract and interior textiles. The "Eco" version uses textile-recycled feedstock from the Jiaren JV | Contract furnishing, hospitality | Trevira CS Eco launched 2026 (Textile Excellence) |
| Textile-recycled PET (Jiaren JV) | Chemical recycling of textile waste into PET chips for spinning. Target up to 100,000 t/yr of textile-recycled PET spinning capacity | Apparel and textile brands with circularity goals | JV announced Nov 2025; closing subject to approvals at announcement |
Financial Narrative
Income Statement
Sources: S&P Global Market Intelligence via StockAnalysis.com (income statement, updated 30 June 2026); company net profit and EPS confirmed against Kaohoon (FY2021 and FY2022) and DAOL (FY2023 to FY2025); MarketScreener consensus page (EBITDA basis).
Company-reported EBITDA (alternative definition, THB million): FY2023 39,000; FY2024 49,656; FY2025 30,959 (DAOL Securities tables). The 2025 One Report summary cites FY2025 EBITDA of THB 32.1bn (-35% YoY). USD reference points (company): FY2022 revenue of USD 18.7bn (Kaohoon) or USD 18.8bn (IVL release), a discrepancy noted, with core EBITDA of USD 2.3bn (+31%). FY2023 revenue USD 15.6bn. FY2024 revenue USD 15.4bn with adjusted EBITDA of USD 1,522m and reported EBITDA of USD 1,408m.
Margin Analysis (%)
Revenue CAGR: FY2021 to FY2025 (4 years): -1.1% per year (THB 468.1bn → THB 447.2bn). FY2022 to FY2025 (peak to latest): -12.0% per year.
Balance Sheet: notes and sources
Notes: Total debt includes lease liabilities. Total common equity includes perpetual subordinated debentures classified as equity under TFRS. At 30 June 2026, total debt was THB 265,534m, cash and short-term investments THB 39,015m, net debt THB 226,519m, and total equity THB 144,920m (S&P). IVL reported liquidity of THB 103bn at end-2Q26 (Kaohoon).
Cash Flow
Buyback note: S&P records THB 15,000m "repurchase of common stock" and THB 14,897m "issuance" in FY2024. These match the timing of IVL's THB 15bn subordinated capital (hybrid) debenture issue rated by TRIS in 2024. They most likely reflect a perpetual hybrid refinancing rather than an ordinary-share buyback. No ordinary-share buyback programme was identified, and the share count has been constant at about 5,615m since FY2021.
Key Ratios
Sources and calculations: ROE, ROA, ROIC, current and quick ratios, D/E, ND/E, ND/EBITDA, asset turnover and inventory turnover come from S&P via StockAnalysis.com. Company-reported leverage: net debt to equity was 1.83x at end-2025, 1.73x at end-1Q26 and 1.56x at end-2Q26. Net debt to EBITDA was 7.6x at 1Q26 and 5.4x at 2Q26 (CLSA, Kaohoon). The company's definitions differ slightly from S&P's.
Recent Quarterly Trajectory
Note: The 2Q25 revenue figure in THB is inferred from 2Q26 revenue of THB 136.0bn being 16% higher (about THB 117bn). 1Q26 plus 2Q26 revenue equals THB 245.3bn, which reconciles with the 1H26 total. 4Q25 net loss of THB 4.7bn reconciles with the FY2025 total of THB -7.35bn (-1.3 - 0.52 - 0.82 - 4.7).
Commentary on Trends, Inflections and Drivers
Revenue. The FY2021 to FY2022 surge (+40%) came from post-pandemic restocking, high crude prices, record ocean freight that inflated import parity in Western markets where IVL is concentrated, and acquisitions (Oxiteno and the Vietnamese packaging business added about 12% to 2Q22 revenue). Revenue then fell 17.5% in FY2023 as feedstock prices and destocking reversed. It was flat in FY2024 and fell another 17.4% in FY2025. The FY2025 decline reflects lower volumes after closures (Rotterdam, Montréal, Sines), lower pass-through feedstock prices, planned US turnarounds and weaker CPET spreads. Because pricing is largely pass-through, revenue is a weak indicator of economic performance. EBITDA per tonne and spreads matter more.
Profitability. Gross margin compressed from 18.6% (FY2021) to 11.9% (FY2025), and operating margin from 8.6% to under 1%. The FY2023 to FY2025 trough reflects:
-
Chinese PTA/PET overcapacity that depressed benchmark spreads.
-
A sharp rise in interest expense, from THB 7.1bn (FY2021) to THB 17.2bn (FY2024), as rates rose on a larger debt base.
-
Large impairments: THB 8.6bn in FY2022, THB 10.7bn in FY2023 and THB 22.5bn in FY2024.
The FY2024 net loss of THB 19.3bn was driven primarily by impairments. Underlying adjusted EBITDA actually rose 10% in USD terms that year. FY2025 had few impairments but weaker operations, with S&P EBITDA down 36% to THB 25.7bn.
Inflection (2026). 1H26 EBITDA rose 61% YoY to THB 29.7bn. 2Q26 alone reached THB 21.7bn, the highest quarterly EBITDA since 2022. The drivers were an exceptional spread spike (China CPET spread of USD 279/t vs. USD 176/t in 1Q26), self-help cost savings (THB 8.2bn of cumulative structural fixed-cost reductions since 2023), and better mix in Indovinya (HVA). Management itself cautions that 2Q26 tailwinds will partly normalise. The China spread had already fallen back to USD 184/t in July 2026 and was estimated at USD 180 to 190/t versus a USD 308/t peak in May 2026 (DAOL).
Balance sheet. Net debt rose from THB 208bn (FY2021) to a peak of THB 244bn (FY2024) as acquisitions (THB 46bn of cash acquisitions in FY2022) and losses eroded equity. Common equity fell from THB 186bn (FY2022) to THB 117.5bn (FY2025) because of losses, impairments and FX translation. As a result, net debt to equity climbed from 1.16x to 1.83x, and net debt to EBITDA reached about 9x on S&P EBITDA in FY2025. The 1H26 recovery brought net debt down to THB 226.5bn and net debt to equity to 1.56x. Goodwill and intangibles are a modest about 9% of total assets, so write-down risk is concentrated in PP&E (THB 282bn).
Cash flow. Cash generation has been more resilient than earnings. Operating cash flow was THB 48.0bn in FY2025 (+37%) despite the net loss, helped by a THB 15.0bn working-capital release (inventory -THB 11.1bn, receivables -THB 14.8bn). Capex was cut from THB 25.6bn (FY2022) to THB 16 to 18bn (FY2024 to FY2025), consistent with TRIS's assumed THB 16 to 20bn per year. FY2025 free cash flow of THB 30.2bn covered dividends (THB 4.8bn) about six times. In 1H26, operating cash flow after maintenance capex rose 78% to THB 25.9bn. The cash conversion cycle shortened to 23 days in FY2025 from 39 days in FY2021, and inventory turnover improved to 5.0x in 2Q26 (company definition).
Returns. ROIC fell from 11.2% (FY2022) to about 1% (FY2025), well below any plausible cost of capital. That gap is the central problem the 2026 to 2028 plan addresses with its explicit "improve returns on capital" priority.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Segment Overview
| Segment | Contents | Key products | Strategic role |
|---|---|---|---|
Combined PET (CPET) | Integrated PET (PTA, PET, rPET), Intermediate Chemicals (US olefins, EO/MEG, MTBE), Specialty PET | PET resin, rPET (Deja brand), PTA, PIA, MEG, EO, ethylene, MTBE | Scale and integration engine; "shale-to-PET" platform |
Indovida (Packaging) | Rigid PET packaging (formerly within CPET) | Preforms, closures, bottles | Downstream consumer-facing growth; merging into EPL |
Indovinya | Surfactants and specialty chemicals (ex-Huntsman, ex-Oxiteno) | Ethoxylates, amines, glycol ethers, specialty surfactants; HVA and Essentials | Higher-margin specialty diversification |
Fibers | Hygiene, Mobility, Lifestyle verticals | Polyolefin and polyester staple fibres, tyre cord, airbag yarn, Trevira fibres | Technical textiles; under restructuring |
Segment revenue (THB Mn)
| Segment revenue (THB Mn) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
CPET excl. Indovida (THB Mn) | — | — | — | 352,270 | 275,957 |
Indovida (THB Mn) | — | — | — | 17,201 | 14,454 |
CPET incl. Indovida, derived (THB Mn) | — | 404,956 | 368,043 | 369,471 | 290,411 |
Indovinya / IOD (THB Mn) | 80,440 | 147,696 | 82,481 | 87,130 | 80,147 |
Fibers (THB Mn) | 117,105 | 131,205 | 110,994 | 113,473 | 100,159 |
Unallocated and eliminations (THB Mn) | — | -27,591 | -20,060 | -24,178 | -17,315 |
Total segment revenue (THB Mn) | 468,108 | 656,266 | 541,458 | 545,896 | 453,402 |
Segment Revenue
| Segment | FY2024 revenue (THB Mn) | FY2025 revenue (THB Mn) | YoY growth | Share of gross segment revenue FY2025 |
|---|---|---|---|---|
CPET excl. Indovida | 352,270 | 275,957 | -21.7% | 58.6% |
Indovida | 17,201 | 14,454 | -16.0% | 3.1% |
Indovinya | 87,130 | 80,147 | -8.0% | 17.0% |
Fibers | 113,473 | 100,159 | -11.7% | 21.3% |
Segment Overview (Annual)
| Segment | FY2024 adjusted EBITDA (USD Mn) | YoY |
|---|---|---|
CPET (incl. Indovida at the time) | 1,012 | +5% |
Indovinya | 352 | +29% |
Fibers | 159 | +26% |
Group adjusted EBITDA | 1,522 | +10% |
Group reported EBITDA | 1,408 | +26% |
Segment Overview — CPET
| Segment | 1Q25 | 2Q25 | 3Q25 | Source |
|---|---|---|---|---|
CPET | 126 | 191 | about 17% lower QoQ (exact figure n/v) | Chemorbis / Packaging South Asia; DAOL; Kaohoon |
Indovida | 21 | 27 | n/v | Packaging South Asia; DAOL |
Indovinya | 89 | 75 | 78 | Packaging South Asia; DAOL; Kaohoon |
Fibers | 47 | 47 | about 35% lower QoQ (exact figure n/v) | Packaging South Asia; DAOL; Kaohoon |
Group adjusted EBITDA | 276 | 330 | 276 to 279 (sources differ) | IVL; Kaohoon; Parqet |
Segment Overview (2)
| Segment | 1Q26 | 2Q26 | 2Q26 YoY | Source |
|---|---|---|---|---|
CPET | 5,500 | 14,433 | +163% | IVL 1Q26 release; Kaohoon |
Indovida | 743 | about 1,300 | Volume +11% YoY | IVL 1Q26 release; DAOL |
Indovinya | 1,700 | 4,688 | +94% (about doubled) | IVL 1Q26 release; Kaohoon; DAOL |
Fibers | 879 | 1,873 | +39% | IVL 1Q26 release; Kaohoon |
Group EBITDA | 8,000 | 21,687 | +129% | IVL; Kaohoon |
Income Statement and Margin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Sales revenue, company-reported (THB Mn) | 468,108 | 656,266 | 541,458 | 541,583 | 447,246 |
Total revenue incl. other income, S&P (THB Mn) | 470,555 | 660,378 | 543,627 | 544,095 | 451,196 |
Revenue growth, sales revenue (%) | 41.2 | 40.2 | -17.5 | 0.0 | -17.4 |
Gross profit, S&P (THB Mn) | 87,427 | 116,057 | 67,588 | 77,778 | 53,792 |
Operating income / EBIT, S&P (THB Mn) | 40,290 | 53,120 | 9,519 | 16,264 | 3,881 |
EBITDA, S&P standardized (THB Mn) | 59,774 | 76,068 | 33,630 | 40,418 | 25,730 |
EBITDA, MarketScreener basis (THB Mn) | 63,825 | 74,772 | 34,373 | 41,078 | 24,681 |
Pre-tax income (THB Mn) | 34,957 | 40,104 | -13,597 | -23,041 | -8,002 |
Income tax expense (THB Mn) | 6,703 | 5,774 | -2,684 | -3,855 | -1,096 |
Net profit attributable, company-reported (THB Mn) | 26,288 | 31,006 | -10,798 | -19,262 | -7,348 |
Net income to common after perpetual debenture interest, S&P (THB Mn) | 25,538 | 30,256 | -11,548 | -20,465 | -8,263 |
EPS basic (THB) | 4.55 | 5.39 | -2.06 | -3.65 | -1.47 |
EPS diluted (THB) | 4.55 | 5.39 | -2.06 | -3.65 | -1.47 |
Dividend per share, by fiscal year (THB) | 1.00 | 1.60 | 0.925 | 0.70 | 0.70 |
Interest expense (THB Mn) | 7,121 | 10,495 | 15,367 | 17,228 | 15,457 |
Depreciation and amortisation, cash flow basis (THB Mn) | 21,548 | 25,387 | 27,103 | 27,151 | 24,675 |
Impairments, restructuring and asset write-downs, S&P (THB Mn) | 593 | 8,645 | 10,727 | 22,465 | -170 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansMargin (%)
| Margin (%) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Gross margin (%) | 18.58 | 17.57 | 12.43 | 14.29 | 11.92 |
Operating (EBIT) margin (%) | 8.56 | 8.04 | 1.75 | 2.99 | 0.86 |
EBITDA margin, S&P (%) | 12.70 | 11.52 | 6.19 | 7.43 | 5.70 |
Net margin, company NP / sales revenue (%) | 5.62 | 4.72 | -1.99 | -3.56 | -1.64 |
Free cash flow margin (%) | 2.94 | 7.93 | 5.36 | 3.51 | 6.68 |
Balance Sheet and Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Total assets (THB Mn) | 541,828 | 623,878 | 590,132 | 541,552 | 523,480 |
Cash and equivalents (THB Mn) | 16,215 | 21,211 | 18,683 | 17,496 | 27,356 |
Cash and short-term investments (THB Mn) | 16,456 | 21,744 | 19,757 | 18,039 | 27,983 |
Short-term debt incl. current LTD and leases (THB Mn) | 45,821 | 67,280 | 69,403 | 73,583 | 61,190 |
Long-term debt incl. leases (THB Mn) | 178,555 | 187,033 | 184,943 | 188,442 | 202,958 |
Total debt (THB Mn) | 224,377 | 254,313 | 254,346 | 262,025 | 264,148 |
Net debt (THB Mn) | 207,921 | 232,569 | 234,590 | 243,986 | 236,164 |
Inventory (THB Mn) | 88,979 | 115,872 | 96,657 | 92,855 | 79,210 |
Goodwill (THB Mn) | 17,411 | 17,888 | 17,584 | 17,083 | 16,017 |
Other intangibles (THB Mn) | 33,149 | 34,016 | 33,969 | 31,000 | 29,542 |
Goodwill and intangibles (THB Mn) | 50,560 | 51,904 | 51,553 | 48,083 | 45,559 |
Total common equity (THB Mn) | 158,769 | 185,990 | 164,362 | 125,951 | 117,527 |
Total equity incl. minorities (THB Mn) | 171,003 | 200,885 | 178,068 | 138,930 | 128,950 |
Working capital (THB Mn) | 15,738 | 13,507 | -11,993 | -8,621 | -3,921 |
Book value per share, S&P (THB) | 25.62 | 30.47 | 26.62 | 19.78 | 18.28 |
Cash Flow
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Operating cash flow (THB Mn) | 33,772 | 77,981 | 53,134 | 35,112 | 48,046 |
Capital expenditure (THB Mn) | -19,959 | -25,631 | -24,009 | -16,029 | -17,887 |
Free cash flow (THB Mn) | 13,813 | 52,350 | 29,124 | 19,083 | 30,159 |
Cash acquisitions (THB Mn) | -2,987 | -46,233 | -68 | -5,574 | -2 |
Change in working capital (THB Mn) | -28,016 | -1,012 | 17,844 | -8,078 | 15,044 |
Common dividends paid (THB Mn) | -5,943 | -8,891 | -7,207 | -4,682 | -4,845 |
Share buybacks, common (THB Mn) | 0 | 0 | 0 | 0 | 0 |
Cash interest paid (THB Mn) | 6,787 | 9,732 | 14,715 | 15,879 | 14,698 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
ROE (%) | 18.43 | 18.46 | -5.76 | -12.11 | -5.16 |
ROA, S&P EBIT-based (%) | 5.06 | 5.70 | 0.98 | 1.80 | 0.46 |
ROIC (%) | 9.20 | 11.20 | 2.25 | 4.09 | 1.04 |
Current ratio (x) | 1.10 | 1.07 | 0.94 | 0.96 | 0.98 |
Quick ratio (x) | 0.49 | 0.44 | 0.40 | 0.42 | 0.43 |
Debt to equity (x) | 1.31 | 1.27 | 1.43 | 1.89 | 2.05 |
Net debt to equity (x) | 1.22 | 1.16 | 1.32 | 1.76 | 1.83 |
Net debt to EBITDA, S&P (x) | 3.48 | 3.06 | 6.98 | 6.04 | 9.18 |
Interest coverage, EBIT / interest (x) | 5.66 | 5.06 | 0.62 | 0.94 | 0.25 |
EBITDA / interest (x) | 8.39 | 7.25 | 2.19 | 2.35 | 1.66 |
Asset turnover (x) | 0.95 | 1.13 | 0.90 | 0.96 | 0.85 |
Inventory turnover (x) | 5.36 | 5.31 | 4.48 | 4.92 | 4.62 |
Days sales outstanding (days) | 41.2 | 30.7 | 34.3 | 35.6 | 29.4 |
Days inventory outstanding (days) | 84.8 | 77.7 | 74.1 | 72.7 | 72.8 |
Days payables outstanding (days) | 86.6 | 71.6 | 78.2 | 72.9 | 78.8 |
Cash conversion cycle (days) | 39.4 | 36.8 | 30.2 | 35.4 | 23.4 |
Revenue History
| Quarter | Revenue | Adjusted / reported EBITDA | Net profit (loss) | Key driver | Source |
|---|---|---|---|---|---|
1Q25 | USD 3.49bn (-9% YoY) | Adj. USD 276m (-30% YoY) | Loss USD 39m (about THB -1.3bn) | US olefin turnarounds, winter freeze | Chemorbis; Globlex |
2Q25 | THB 117.6bn (+/- 11% YoY drop in USD terms) | Adj. USD 330m; reported THB 9.3bn | Loss THB 521m; core profit THB 595m | Volume normalisation; USD 48m higher energy cost | IVL 1H25 release; Globlex |
3Q25 | USD 3.39bn | Adj. USD 276 to 279m (-35% YoY) | Loss THB 818m | Seasonal PET weakness, stock loss | Kaohoon; Parqet |
4Q25 | n/v | n/v | Loss THB 4.7bn | Margin pressure, impairments | DAOL (4 Mar 2026) |
1Q26 | THB 109.3bn (+7% QoQ) | Reported THB 8.0bn (+89% QoQ) | Loss about THB 2.8bn (impairment charges) | Volume and margin recovery | IVL 1Q26 release; DAOL |
2Q26 | THB 136.0bn (+16% YoY) | Reported THB 21.7bn (+129% YoY); margin about 16% | Profit THB 5.96bn (EPS THB 1.02); core THB 9.17bn | Asian supply tightness; CPET spread USD 279/t | Kaohoon; CLSA |
Region revenue (USD Bn)
| Region revenue (USD Bn) | FY2023 | FY2024 |
|---|---|---|
USA / Americas as labelled (USD Bn) | 6.5 | 7.7 |
Europe (USD Bn) | 3.5 | 3.1 |
Asia (USD Bn) | 4.5 | 4.47 |
Rest of world (USD Bn) | 1.1 | 0.13 |
Total (USD Bn) | 15.6 | 15.4 |
Geographic Revenue
| Region | FY2023 (USD Bn) | FY2024 (USD Bn) | Change | Drivers |
|---|---|---|---|---|
USA / Americas | 6.5 | 7.7 | +18% (partly reclassification) | Integrated US platform (shale-advantaged EO/MEG); Indovinya North America recovery; tariffs raising import parity |
Europe | 3.5 | 3.1 | -11% | Rotterdam PTA/PET closure (2024), Sines PTA mothballed, high energy costs, Asian imports |
Asia | 4.5 | 4.47 | -1% | Chinese oversupply capping spreads; stable volumes |
Rest of world | 1.1 | 0.13 | -88% (likely reclassification) | n/v |
Segment Overview (3)
| Segment | Principal geographic exposure |
|---|---|
CPET | US (integrated olefins, EO/MEG, PET), Europe (PET, recycling), Asia (Thailand, Indonesia, China, India PET/PTA), Africa (Nigeria), Brazil (Suape PET) |
Indovida | Emerging markets: India, Vietnam, Africa, Southeast Asia |
Indovinya | Brazil and Latin America (ex-Oxiteno), US (ex-Huntsman), Mexico, Uruguay, Asia |
Fibers | Europe (Trevira, mobility; shrinking), US (hygiene), Asia (Thailand, China, India), Brazil (exited 2026) |
Share price metric
| Share price metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Year-end share price (THB) | 36.85 | 35.87 | 24.91 | 23.47 | 15.73 |
Year-end market cap (THB Mn) | 242,829 | 228,793 | 152,997 | 139,802 | 90,394 |
Year-end enterprise value (THB Mn) | 461,224 | 498,741 | 413,741 | 368,821 | 345,216 |
Price to book (x) | 1.42 | 1.14 | 0.86 | 1.01 | 0.70 |
EV to EBITDA, S&P (x) | 7.72 | 6.56 | 12.30 | 9.13 | 13.42 |
EV to sales (x) | 0.98 | 0.76 | 0.76 | 0.68 | 0.77 |
Dividend yield (%) | 2.71 | 4.46 | 3.71 | 2.98 | 4.45 |
Period return (price only)
| Period return (price only) | Return |
|---|---|
Year-to-date 2026 (THB 15.73 → THB 27.75 on 6 Oct 2026) | +76.4% |
Since end-2023 (about 2.8 years; THB 24.91 → 27.75) | +11.4% |
Since end-2021 (about 4.8 years; THB 36.85 → 27.75) | -24.7% |
52-week range | THB 14.60 (Nov 2025 low) to about THB 29.25 (Sep 2026) |
Valuation Multiples
| Multiple | IVL (current) | Basis |
|---|---|---|
Market cap | about THB 155.8bn | 5,614.6m shares |
Enterprise value | about THB 395bn | Market cap + net debt THB 226.5bn (2Q26) + minorities THB 12.6bn |
P/E (TTM) | Not meaningful (TTM net loss THB 2.4bn) | S&P |
P/E (2026E) | about 24x (S&P forward P/E at THB 29.25: 24.4x); about 29x on DAOL 2026E NP of THB 5.4bn | S&P; DAOL |
EV / EBITDA (TTM) | about 11.6x (TTM S&P EBITDA THB 34.0bn) | Calculated |
EV / EBITDA (2026E) | about 8.4x (consensus EBITDA THB 47.1bn) | MarketScreener |
EV / Sales (TTM) | about 0.86x | Calculated |
P / B | about 1.07x | S&P (1.13x at THB 29.25) |
P / FCF (TTM) | about 3.6x | S&P (3.81x at THB 29.25) |
Analyst Ratings & Targets
| Broker | Date | Rating | Target price (THB) | View |
|---|---|---|---|---|
CLSA | Nov 2025 | Outperform | 24 (raised) | 3Q25 loss better than feared; 2026 turnaround expected |
Globlex | 14 Aug 2025 | BUY | 28 (7x 2025E EV/EBITDA) | Positive on 2H25 to 2027 on China demand, US tariffs and cost savings |
DBS | Nov 2025 | Cautious (rating n/v) | n/v | Cautious on 2026 |
JPMorgan | Aug 2026 | Diverging view vs. CLSA after 2Q26 (stance n/v) | n/v | Debate on sustainability of spreads |
DAOL Securities | 13 Aug 2026 | n/v | n/v | Expects YoY recovery in 3Q26; 2026E NP THB 5.4bn; 2027E THB 6.2bn |
Income Statement
| Consensus (THB Mn) | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
Revenue (THB Mn) | 488,839 | 489,161 | 496,922 |
EBITDA (THB Mn) | 47,088 | 49,138 | 51,635 |
EBIT (THB Mn) | 24,070 | 23,344 | 25,528 |
Pre-tax profit (THB Mn) | 10,106 | 11,521 | 12,254 |
Dividend metric
| Dividend metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Dividend per share by fiscal year (THB) | 1.00 | 1.60 | 0.925 | 0.70 | 0.70 |
Payout ratio (%) | 22.6 | 28.7 | — | — | — |
Common dividends paid (THB Mn) | 5,943 | 8,891 | 7,207 | 4,682 | 4,845 |
Credit Ratings
| Agency | Rating | Outlook | Date / note |
|---|---|---|---|
TRIS Rating (Thailand), company rating | AA- | Negative (revised from Stable) | 2024 rationale: risk that deleveraging falls short. 2025 to 2026 actions n/v |
TRIS, senior unsecured debentures | AA- | Negative | Same |
TRIS, subordinated capital (hybrid) debentures | A | Two notches below company rating; THB 15bn issue rated A (2024) | TRIS |
TRIS, IVGS USD 300m guaranteed debentures | AA- (equal to IVL) | Stable at the time | TRIS (2023) |
Moody's / S&P / Fitch | No international issuer ratings identified | — | n/v |
Capital Markets
| Item | Amount (THB Mn) | Date |
|---|---|---|
Short-term borrowings | 36,618 | FY2025 |
Current portion of long-term debt | 22,207 | FY2025 |
Current lease liabilities | 2,365 | FY2025 |
Long-term debt (over 1 year) | 194,592 | FY2025 |
Long-term leases | 8,366 | FY2025 |
Total debt | 264,148 | FY2025 |
Short-term borrowings + current LTD (30 Jun 2026) | 51,142 | 2Q26 |
Liquidity | about THB 103bn | 2Q26 (Kaohoon) |
Analyst Conclusions
Management Guidance
2026: Management is "confident" in its 2026 expectations. Priorities are sustainable earnings under normalised spreads, FCF conversion, absolute net-debt reduction and higher returns. Management expects some exceptional 2Q26 tailwinds to normalise (1H26 release, 11 Aug 2026).
2028: EBITDA doubling, net debt to equity of about 1.1x, net debt to EBITDA below 3.0x (CMD, 4 Mar 2026).
Deleveraging: Management aims for net debt to EBITDA below 3x by 2028 (CLSA summary).
Consensus Growth Expectations
Consensus (MarketScreener) expects FY2026E revenue of THB 488.8bn (+9.3%) and EBITDA of THB 47.1bn (+91% on consensus's FY2025 base). EBITDA growth then slows to about 4 to 5% per year through 2028. DAOL forecasts a 2026E net profit of THB 5.4bn, a return to profitability after three loss years.
Bull Case
-
Self-help plus a cyclical floor equals durable earnings. THB 8.2bn of structural cost cuts, a smaller European footprint, and inventory turnover at 5.0x mean that even normalised spreads (USD 180 to 190/t in China, above 2025 levels) should support EBITDA well above FY2025's THB 31bn. 1H26 EBITDA of THB 29.7bn nearly equals the full FY2025 figure.
-
Rapid deleveraging creates equity value. FY2025 FCF was THB 30bn and 1H26 operating cash flow after maintenance capex was THB 25.9bn. Every THB 10bn of debt reduction shifts value to equity (market cap of about THB 156bn against net debt of THB 226.5bn). ND/E already hit the 2026 target early.
-
Portfolio crystallisation. The EPL merger gives IVL 51.8% of a listed, roughly USD 2bn packaging company, creating a visible mark-to-market for packaging. An Indovinya listing or partial monetisation could follow. Indovinya HVA (about 80% of segment EBITDA) deserves a specialty multiple.
Bear Case
-
2Q26 was a spike, not a new base. The China CPET spread fell 34% from 2Q26 to July 2026 (USD 279 → 184/t). Chinese capacity growth continues, and Alpek guides flat 2026 EBITDA on continued margin compression. At about 24 to 29x 2026E earnings, the stock already prices in much of the recovery.
-
Leverage remains a constraint. Net debt is still about THB 226.5bn, ND/EBITDA was 5.4x at 2Q26, interest cost runs at about THB 15bn per year, and TRIS has had a Negative outlook since 2024. A spread relapse would quickly reverse the deleveraging narrative, and dividends have been paid through loss years.
-
Recurring impairments and restructuring. Charges recurred in 1Q26 and 2Q26 (THB 1.23bn of restructuring plus THB 0.8bn of impairments in 2Q26), and further European exits (Steinfort through 2027) are underway. Reported earnings may continue to trail "core" figures, eroding confidence in adjusted metrics.
Key Catalysts and Monitorables (next 12 months)
| Catalyst / monitorable | Expected timing | What to watch |
|---|---|---|
| 3Q26 results | about mid-November 2026 | Whether EBITDA holds above THB 12 to 15bn per quarter as spreads normalise; DAOL expects YoY recovery |
| FY2026 results and CMD 2027 | about late February / early March 2027 | FY2026 EBITDA vs. consensus THB 47.1bn; update on 2028 targets |
| EPL–Indovida merger completion | By about March 2027 | Remaining shareholder, creditor and NCLT approvals; deconsolidation or consolidation accounting |
| China PET / PTA spreads and new capacity | Ongoing | Spread trajectory vs. USD 180 to 190/t |
| TRIS rating review | Ongoing | Outlook resolution (Negative → Stable or downgrade) |
| Net debt trajectory | Quarterly | Absolute net debt below THB 220bn; ND/E path to about 1.1x |
| Further European closures and divestments; land sales | Ongoing | Cash proceeds; one-off charges |
| Energy prices and Middle East geopolitics | Ongoing | US and EU energy costs; shipping routes |
| Indovinya HVA momentum | Quarterly | Segment EBITDA vs. 2Q26 THB 4.7bn |
| Dividend decisions | Interim (August) and final (March) | Signal on capital-allocation balance |
Analyst Verdict
Indorama Ventures enters late 2026 at a genuine but fragile inflection. Three years of losses (cumulative net losses of about THB 37bn over FY2023 to FY2025), about THB 42bn of impairments and leverage near 9x EBITDA forced a decisive strategic reset. Management deserves credit for the speed and scale of that reset: THB 8.2bn of structural cost removal, exits from loss-making European PTA, PET, recycling and mobility assets, disciplined capex of THB 16 to 18bn, and a working-capital release that delivered THB 30bn of free cash flow in a loss year. The 2Q26 result (EBITDA THB 21.7bn, net profit THB 6.0bn) shows the operating leverage this leaner platform carries when spreads cooperate.
The central analytical question is how much of 1H26 is structural. Our reading is that perhaps half of the 2Q26 step-up was cyclical (an Asian supply squeeze that pushed China CPET spreads to about USD 279 to 308/t) and is already fading. The remainder reflects durable self-help and mix improvements, especially in Indovinya HVA and Indovida. On consensus 2026E EBITDA of about THB 47bn, the stock trades at about 8.4x EV/EBITDA. That is undemanding for a recovered cyclical, but not cheap given about THB 227bn of net debt, a Negative TRIS outlook and continued restructuring charges.
The EPL merger is the most underappreciated element. It converts a sub-scale captive packaging unit into a majority stake in a listed, roughly USD 2bn emerging-markets packaging platform, and sets a template for crystallising value in Indovinya.
Verdict: a constructive but execution-dependent recovery story. The 2028 targets (EBITDA doubling, net debt to EBITDA below 3x) are credible only if normalised spreads stay above 2025 levels and absolute net debt falls meaningfully. Investors should anchor on quarterly FCF and absolute net-debt reduction, not on headline EBITDA. Those are the variables that will determine whether the 2026 rerating proves durable or becomes another cyclical peak in a structurally oversupplied industry.
Appendix A: Source Register
| Source | Content used |
|---|---|
| IVL earnings releases: FY2021, 2Q22, FY2022, FY2024 (26 Feb 2025), 1H25 (13 Aug 2025), 1Q26 (18 May 2026), 1H26 (11 Aug 2026) | Financial results, segment commentary, strategy |
| IVL Capital Markets Day release (4 Mar 2026) | 2026 to 2028 targets |
| IVL leadership releases (2 Nov 2021; 1 Jul 2024) | Executive changes |
| IVL board competency matrices (Apr 2020; May 2022); Sri Prakash Lohia board profile | Board composition |
| IVL 2025 One Report summary (SustainabilityReports.com) | FY2025 EBITDA, OCF, cost savings, recycling |
| IVL Sustainability Report Executive Summary 2025; IVL awards pages | ESG ratings |
| IVL revenue-by-region factsheets (2023, 2024) | Geographic revenue |
| S&P Global Market Intelligence via StockAnalysis.com (updated Jun to Aug 2026) | Standardized financial statements and ratios |
| SET quote page (6 to 7 Oct 2026) | Share price |
| MarketScreener (Sep 2026) | Consensus estimates |
| DAOL Securities (15 Aug 2025; 4 Mar 2026; 13 Aug 2026) | Quarterly results, net profit series, spreads |
| Kaohoon International (2022 to 2026) | Results, broker views (CLSA, JPMorgan, DBS), divestments |
| Globlex via Settrade (14 Aug 2025) | 2Q25 analysis and target price |
| TRIS Rating reports (2017 to 2024) | Credit ratings, debentures |
| EPL / Indovida joint release and coverage (29 to 30 Mar 2026) | Merger terms |
| Eurofound ERM factsheets 204357 and 300431 (2026) | Longlaville closure, employee count |
| Paperjam; Woxx (via Ground News) (Jul 2026) | Steinfort closure |
| ICIS (Apr 2025); Polimerica; Wood Mackenzie | Sines, Rotterdam, Montréal |
| Ecotextile (May 2026) | IVFB sale |
| Recycling International; Textination; Textile Excellence; texspacetoday | Jiaren JV, Trevira CS Eco |
| Alpek 4Q25 report and Indian Chemical News (Feb 2026) | Peer benchmark |
| Simply Wall St (2026) | CEO compensation, tenure, insider ownership |
| World Economic Forum organisation and author profiles | Footprint, CEO background |
| Chemorbis; Packaging South Asia; Man-Made Fibers | 1Q25 segment data |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Title | Tenure / since | Prior roles | Education | Age | Total compensation |
|---|---|---|---|---|---|---|
Aloke Lohia | Vice Chairman and Group CEO; also Non-Executive Director, EPL Ltd (since 27 May 2025) | Group CEO about 16.6 years | Founder of IVL's PET business; Honorary Investment Adviser, Thailand Board of Investment | B.Com, Delhi University; Honorary Doctorate, Rajamangala University of Technology Krungthep | 66 | THB 128.0m (FY2025; salary 43.8% of total); direct ownership 0.018% |
Dilip Kumar (D.K.) Agarwal | Deputy Group CEO and Group CFO (from 1 Jul 2024) | IVL board member since about 2010 | CEO / Executive President, CPET; took on CFO responsibilities from 2021 | n/v | about 68 (64 in 2022) | n/v |
Yashovardhan (Yash) Lohia | Executive Director; Executive President, Petchem Special Projects (from Jul 2024); Chairman, ESG Council | Board since about 2019 | Leader of recycling and sustainability initiatives | n/v | about 38 (34 in 2022) | n/v |
Suchitra Lohia | Executive Director | Board since about 2009 | n/v | n/v | about 61 (57 in 2022) | n/v |
Udey Paul Singh (Uday) Gill | Executive Director (senior executive) | Board since about 2011 | n/v | n/v | about 72 (68 in 2022) | n/v |
Muthukumar Paramasivam | President and Co-Leader, Combined PET | Since 1 Jul 2024 | n/v | n/v | n/v | n/v |
Kumar Sambhaw Ladha | President and Co-Leader, Combined PET | Since 1 Jul 2024 | n/v | n/v | n/v | n/v |
Diego Boeri | Executive President, Fibers | Disclosed 2025 | n/v | n/v | n/v | n/v |
Sunil Marwah | CEO, Indovida (to report to EPL's Hemant Bakshi post-merger) | n/v | n/v | n/v | n/v | n/v |
Indovinya head | n/v (Alastair Port was COO of IOD in 2021) | n/v | n/v | n/v | n/v | n/v |
Ashok Jain | Controller (Banking and Finance, Consolidation, Tax, M&A); prior disclosure Nov 2021 | 2021 | n/v | n/v | n/v | n/v |
Klaus Holz | Chief Human Resources Officer (from 1 Jan 2022) | 2022 | n/v | n/v | n/v | n/v |
Chief Sustainability Officer | Named role in 2025 Sustainability Report (individual n/v) | n/v | n/v | n/v | n/v | n/v |
Board of Directors
| Director | Role | Type | Nationality | Notes |
|---|---|---|---|---|
Sri Prakash Lohia | Chairman | Non-Executive | Indonesian | Director since 19 Sep 2009; founder of Indorama Corporation; B.Com Delhi |
Aloke Lohia | Vice Chairman, Group CEO | Executive | Indian | Confirmed 2026 |
Suchitra Lohia | Director | Executive | Indian | Confirmed as board member (Simply Wall St 2026) |
Amit Lohia | Director | Non-Executive | Indian | Vice-Chairman of Indorama Corporation; Wharton finance degree |
Dilip Kumar Agarwal | Director | Executive | Indian | Deputy Group CEO and Group CFO |
Udey Paul Singh Gill | Director | Executive | Indian | n/v current |
Yashovardhan Lohia | Director | Executive | Indian | Confirmed 2026 |
Rathian Srimongkol | Lead Independent Director and Vice Chairman | Independent | Thai | About 16.6 years tenure (Simply Wall St) |
Kanit Si | Director | Independent | Thai | 2022 composition |
Dr. Siri Ganjarenrdee | Director | Independent | Thai | 2022 composition |
Russell Leighton Kekuewa | Director | Independent | American | 2022 composition |
Tevin Vongvanich | Director | Independent | Thai | 2022 composition |
Kaisri Nuengsigkapian | Director | Independent | Thai | 2022 composition (female) |
Harald Link | Director | Independent | Thai | Appointed 1 Nov 2021 |
Board & Management Changes
| Date | Change | Context |
|---|---|---|
2 Nov 2021 | CFO Sanjay Ahuja rotated to interim COO of CPET; D.K. Agarwal adds CFO duties; C. Kenneally (Fibers COO) and A. Port (IOD COO) join the Indorama Management Council; Klaus Holz becomes CHRO (from Jan 2022), replacing retiring Roberto Bettini | Leadership rotation and succession building |
1 Jul 2024 | D.K. Agarwal moves from CPET Executive President to Deputy Group CEO and Group CFO; Paramasivam and Ladha become CPET co-presidents; Yash Lohia becomes Executive President, Petchem Special Projects | Next-generation leadership under IVL 2.0 |
| 2025 | Diego Boeri leads Fibers as Executive President | Fibers transformation and Jiaren JV |
27 May 2025 | Aloke Lohia joins EPL board as Non-Executive Non-Independent Director | EPL investment |
Mar 2026 | Post-merger, the Indovida CEO will report to EPL's MD and Global CEO Hemant Bakshi | Packaging governance shift |
Major Shareholders
| Holder | Stake | Notes |
|---|---|---|
Indorama Resources Ltd. (Lohia family) | Majority / controlling stake; exact 2026 % n/v | Identified as principal shareholder in DAOL research tables |
Thai NVDR Co. (IVL-R) | n/v | Conduit for foreign investors |
Other top-10 institutional holders | n/v | — |
Aloke Lohia (direct) | 0.018% | Simply Wall St |
Lead Independent Director (direct) | 0.018% | Simply Wall St |
Other directors (direct) | about 0.00002% to 0.036% each | Simply Wall St |
Competitive Landscape
Competitors by Segment
| Segment | Competitor | HQ | Positioning vs. IVL |
|---|---|---|---|
CPET (PET/PTA) | Alpek S.A.B. de C.V. | Mexico | #1 PTA/PET/rPET in the Americas; 2025 revenue USD 6.59bn; Polyester about 71% of sales; also hit by overcapacity |
CPET | Far Eastern New Century | Taiwan | Integrated polyester and PET; Corpus Christi JV partner |
CPET | China Resources Chemical (CR Chem) | China | Large Chinese PET resin capacity |
CPET | Jiangsu Sanfangxiang | China | Large Chinese PTA/PET |
CPET | Wankai New Materials | China | Chinese PET resin capacity |
CPET / Fibers | Reliance Industries | India | Integrated PX-PTA-PET-polyester fibre giant; strong in India |
CPET (intermediates) | Hengli / Rongsheng / Hengyi (China PX-PTA complexes) | China | Low-cost integrated PX-PTA; drivers of oversupply |
CPET (MEG / olefins) | SABIC; Lotte Chemical; Dow | KSA / Korea / USA | MEG and EO competition |
Indovinya | BASF; Dow; Clariant; Croda; Stepan; Nouryon; Sasol; Evonik | Global | Surfactants and specialty chemical peers, mostly larger and more specialty-weighted |
Fibers (Mobility) | Hyosung Advanced Materials; Kordsa; Kolon; Toray | Korea / Türkiye / Japan | Tyre cord and airbag yarn leaders; Asian cost competition behind IVL's European exits |
Fibers (Hygiene / Lifestyle) | Toray; Chinese polyester staple fibre producers | Japan / China | Commodity and technical fibres |
Indovida | Alpla; Amcor; Retal; local converters | Austria / Australia-UK / Cyprus | Rigid packaging peers (comparative data n/v) |
Peer Comparison FY2025
| Metric | Indorama Ventures | Alpek | Peer 2 (Reliance / FENC) | Peer 3 (BASF / Stepan) |
|---|---|---|---|---|
Revenue | THB 447.2bn (about USD 13.5bn at about THB 33/USD) | USD 6.59bn (-13% YoY) | n/v | n/v |
Revenue growth FY2025 | -17.4% (THB) | -13% (USD) | n/v | n/v |
EBITDA | THB 31 to 32bn company basis (about USD 0.95bn); THB 25.7bn S&P | Comparable USD 489m (-30%); reported USD 418m (-35%) | n/v | n/v |
EBITDA margin | 5.7% (S&P) to about 7% (company) | about 7.4% (comparable) | n/v | n/v |
Net debt to EBITDA | 9.2x (S&P FY2025); 5.4x (company, 2Q26) | 4.4x | n/v | n/v |
R&D intensity | — | Not disclosed (n/v) | n/v | n/v |
2026 outlook | EBITDA doubling ambition by 2028; strong 1H26 | Comparable EBITDA guidance USD 450 to 500m (flat to down) | n/v | n/v |
“—” = not publicly disclosed.
Recent Developments
--



